HOLX insider updates holdings to 47,336 shares after option exercise

Rhea-AI Filing Summary

Hologic (HOLX) reported an insider transaction by a company director on 10/20/2025. The director exercised 7,402 non-qualified stock options at $36.04 per share (code M) and on the same day sold 7,402 shares at an average price of $73.07 (code S). Following these transactions, the director beneficially owns 47,336 shares, held directly. The activity was carried out under a Rule 10b5-1 trading plan adopted on February 19, 2025. The exercised option was set to expire on March 2, 2026.

Insider Trade Summary

Net Seller: 7,402 shares ($540,864)

Net Sell 3 txns

Insider Stamoulis Christiana

Role Director

Sold 7,402 shs ($541K)

Type	Security	Shares	Price	Value
Exercise	Non-qualified Stock Option (Right to Buy)	7,402	$0.00	--
Exercise	Common Stock	7,402	$36.04	$267K
Sale	Common Stock	7,402	$73.07	$541K

Holdings After Transaction: Non-qualified Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 54,738 shares (Direct)

Footnotes (1)

1. Transaction pursuant to an existing Rule 10b5-1 trading plan adopted February 19, 2025 to exercise and sell stock options expiring March 2, 2026. Options became exercisable on the date of the 2017 Annual Meeting of Stockholders.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stamoulis Christiana

(Last) (First) (Middle)

250 CAMPUS DRIVE

(Street)

MARLBOROUGH MA 01752

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/20/2025		M		7,402(1)	A	$36.04	54,738	D
Common Stock	10/20/2025		S		7,402(1)	D	$73.07	47,336	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$36.04	10/20/2025		M			7,402	(2)	03/02/2026	Common Stock	7,402	$0	0	D

Explanation of Responses:

1. Transaction pursuant to an existing Rule 10b5-1 trading plan adopted February 19, 2025 to exercise and sell stock options expiring March 2, 2026.

2. Options became exercisable on the date of the 2017 Annual Meeting of Stockholders.

	/s/ Mark W. Irving, attorney-in-fact for Ms. Stamoulis	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity was reported for HOLX?

A company director exercised 7,402 options at $36.04 and sold 7,402 shares at $73.07 on 10/20/2025.

How many HOLX shares does the insider hold after the transaction?

The director beneficially owns 47,336 shares, held directly.

Was the HOLX insider trade under a Rule 10b5-1 plan?

Yes. The transactions were executed pursuant to a Rule 10b5-1 plan adopted on February 19, 2025.

What were the terms of the exercised HOLX stock options?

They were non-qualified stock options with a $36.04 exercise price and a stated expiration of March 2, 2026.

What transaction codes were used in the HOLX Form 4?

Code M for option exercise and code S for open-market sale on 10/20/2025.

What is the issuer and ticker in this Form 4?

The issuer is Hologic, Inc. with ticker HOLX.